🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.68
-0.16 (-2.74%)
Nov 20, 2026, 5:29 PM CET

AlzeCure Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
231.9350.3431.529.125.5841.74
Cash & Short-Term Investments
231.9350.3431.529.125.5841.74
Cash Growth
291.85%59.81%8.24%13.77%-38.73%-62.88%
Accounts Receivable
--0.04---
Other Receivables
2.093.341.771.471.381.54
Receivables
2.093.341.81.471.381.54
Prepaid Expenses
1.371.20.611.040.550.92
Other Current Assets
-0.09----
Total Current Assets
235.454.9633.931.6127.5144.2
Property, Plant & Equipment
3.194.065.330.380.851.42
Other Intangible Assets
0.020.020.020.020.020.02
Other Long-Term Assets
--0--42.460.01
Total Assets
238.659.0439.253270.8445.65

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.134.162.692.694.855.97
Accrued Expenses
9.326.675.254.955.186.38
Current Portion of Leases
-1.31.3---
Current Unearned Revenue
-11.06----
Other Current Liabilities
4.940.380.310.590.330.32
Total Current Liabilities
18.423.569.558.2310.3512.67
Long-Term Leases
1.722.563.64---
Total Liabilities
20.1226.1213.188.2310.3512.67

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3.72.872.211.551.270.94
Additional Paid-In Capital
527.25453.27399.43362.44361.98278.84
Retained Earnings
-312.46-423.22-375.57-340.22-303.05-246.81
Comprehensive Income & Other
----0.28-
Shareholders' Equity
218.4832.9226.0723.7760.4832.97
Total Liabilities & Equity
238.659.0439.253270.8445.65

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.723.864.93---
Net Cash (Debt)
230.2246.4826.5729.125.5841.74
Net Cash Growth
308.51%74.96%-8.71%13.77%-38.73%-62.88%
Net Cash Per Share
1.780.460.340.470.541.11
Filing Date Shares Outstanding
144.51114.9188.362.0962.0937.77
Total Common Shares Outstanding
144.51114.9188.362.0962.0937.77
Working Capital
21731.424.3623.3817.1531.53
Book Value Per Share
1.510.290.300.380.970.87
Tangible Book Value
218.4732.926.0523.7660.4732.96
Tangible Book Value Per Share
1.510.290.300.380.970.87
Machinery
-3.023.022.92.92.9